23.61
Surgery Partners Inc stock is traded at $23.61, with a volume of 818.13K.
It is up +0.90% in the last 24 hours and down -8.45% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$23.40
Open:
$23.42
24h Volume:
818.13K
Relative Volume:
0.62
Market Cap:
$3.01B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-87.44
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
-2.28%
1M Performance:
-8.45%
6M Performance:
-23.84%
1Y Performance:
-17.68%
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SGRY
Surgery Partners Inc
|
23.61 | 3.01B | 2.89B | -33.80M | 204.10M | -0.27 |
![]()
HCA
Hca Healthcare Inc
|
314.79 | 78.18B | 70.60B | 5.76B | 5.64B | 21.97 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
23.17 | 13.60B | 20.87B | 715.14M | 1.67B | 1.2209 |
![]()
DVA
Davita Inc
|
141.12 | 12.38B | 12.67B | 827.68M | 1.42B | 9.27 |
![]()
THC
Tenet Healthcare Corp
|
119.51 | 11.67B | 20.97B | 3.13B | 2.39B | 31.21 |
![]()
UHS
Universal Health Services Inc
|
163.99 | 10.66B | 15.42B | 1.03B | 956.84M | 15.02 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-16-24 | Initiated | BofA Securities | Buy |
Oct-14-24 | Initiated | UBS | Buy |
Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jun-28-24 | Initiated | Macquarie | Outperform |
Mar-06-24 | Initiated | Barclays | Equal Weight |
Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
May-12-23 | Initiated | Mizuho | Buy |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-10-22 | Resumed | Citigroup | Buy |
Nov-30-21 | Initiated | Barclays | Overweight |
Nov-29-21 | Upgrade | Stifel | Hold → Buy |
Nov-01-21 | Initiated | JP Morgan | Neutral |
Oct-18-21 | Initiated | SVB Leerink | Outperform |
Sep-10-21 | Initiated | Cowen | Market Perform |
Jun-23-21 | Resumed | Stifel | Hold |
Sep-17-20 | Reiterated | The Benchmark Company | Buy |
Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
Jan-14-20 | Reiterated | The Benchmark Company | Buy |
Nov-16-18 | Initiated | UBS | Neutral |
Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
Jun-28-18 | Upgrade | Stifel | Sell → Hold |
Jan-30-18 | Reiterated | The Benchmark Company | Buy |
Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
Aug-09-17 | Downgrade | Stifel | Hold → Sell |
Apr-24-17 | Reiterated | Stifel | Hold |
Mar-10-17 | Downgrade | Stifel | Buy → Hold |
Jan-31-17 | Initiated | The Benchmark Company | Buy |
Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
Oct-27-15 | Initiated | Stifel | Buy |
Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Surgery Partners’ chief strategy officer Marissa Brittenham sells $76,028 in stock - Investing.com India
U.S. Ambulatory Surgery Center Market Set to Witness Significant Growth by 2025-2032: AmSurg Corp., Surgery - EIN News
Surgery Partners (NASDAQ:SGRY) Price Target Lowered to $33.00 at Macquarie - Defense World
(SGRY) Trading Report - Stock Traders Daily
Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating - Marketscreener.com
Earnings call transcript: Surgery Partners Inc Q4 2024 beats forecasts By Investing.com - Investing.com Australia
Surgery Partners, Inc. SEC 10-K Report - TradingView
Surgery Partners, Inc. to Host Earnings Call - ACCESS Newswire
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2024 Earnings Call Transcript - MSN
Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates - MSN
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital - Bain Capital
Why Surgery Partners’ Stock Is Facing Turbulence - TipRanks
Surgery Partners: Strong Growth and Strategic Positioning Drive Buy Rating - TipRanks
Surgery Partners Delays Annual Report Filing - TipRanks
Surgery Partners stock price target cut to $35 by Benchmark - Investing.com India
UBS cuts Surgery Partners stock target to $34, maintains Buy rating - Investing.com India
KeyBanc maintains Sector Weight on Surgery Partners stock - Investing.com India
UBS cuts Surgery Partners stock target to $34, maintains Buy rating By Investing.com - Investing.com South Africa
KeyBanc maintains Sector Weight on Surgery Partners stock By Investing.com - Investing.com UK
UBS Cuts Price Target on Surgery Partners to $34 From $38, Keeps Buy Rating -March 04, 2025 at 08:55 am EST - Marketscreener.com
Surgery Partners price target lowered to $35 from $40 at Benchmark - TipRanks
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion - Yahoo Finance
Surgery Partners outlines 2025 guidance with $3.3B-$3.45B revenue target, driven by high acuity growth - MSN
Surgery Partners Reports Strong Revenue Growth for 2024 - TipRanks
Surgery Partners Inc. Reports Record Growth in Earnings Call - TipRanks
Earnings call transcript: Surgery Partners Inc Q4 2024 beats forecasts - Investing.com India
Healthcare Companies Excel In Q1 2024 Earnings Reports - Evrim Ağacı
Surgery Partners Surges on Strong Q4 Results and Bain Capital Pr - GuruFocus.com
Surgery Partners: Q4 Earnings Snapshot - mySA
Surgery Partners Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Surgery Partners Inc (SGRY) Q4 2024 Earnings: Revenue Surpasses Estimates at $864.4 Million, Net Loss Reported - GuruFocus.com
Surgery Partners Surpasses Q4 2024 Revenue Expectations by 4.3%News and Statistics - IndexBox, Inc.
Surgery Partners Inc earnings beat by $0.05, revenue topped estimates - Investing.com Australia
Surgery Partners beats Q4 estimates, shares rise nearly 4% on strong outlook By Investing.com - Investing.com South Africa
Surgery Partners beats Q4 estimates, shares rise nearly 4% on strong outlook - Investing.com Canada
Surgery Partners Sees Increase In Full-year Revenue; Stock RisesUpdate - Nasdaq
Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations By Stock Story - Investing.com Canada
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance - The Manila Times
Earnings Flash (SGRY) Surgery Partners Reports Q4 Adjusted EPS $0.44, vs. FactSet Est of $0.38 - Marketscreener.com
Surgery Partners: Q4 Earnings Snapshot -March 03, 2025 at 07:44 am EST - Marketscreener.com
Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations - Yahoo Finance
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surgery Partners Inc Stock (SGRY) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Baldock Jennifer | Chief Admin & Dev Officer |
Mar 10 '25 |
Sale |
23.97 |
3,008 |
72,102 |
236,659 |
Burkhalter Danielle | Chief Human Resources Officer |
Mar 10 '25 |
Sale |
24.14 |
1,240 |
29,934 |
44,913 |
Webb William Trenton | American Group President |
Mar 10 '25 |
Sale |
24.06 |
2,057 |
49,491 |
74,659 |
Doherty David T | Chief Financial Officer |
Mar 10 '25 |
Sale |
24.02 |
6,733 |
161,727 |
150,868 |
Brittenham Marissa | Chief Strategy Officer |
Mar 10 '25 |
Sale |
24.09 |
3,156 |
76,028 |
63,408 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):